Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
Investigational New Drugs, 10/08/09
Park IH et al. – Lovastatin can overcome gefitinib resistance, in NSCLC cells with K–Ras mutations, by down regulation of RAS protein, which leads to inhibition of both RAF/ERK and AKT pathways.
Related Articles
Treatment after the Failure of Gefitinib in Patients with Advanced or Recurrent Non-small Cell Lung Cancer
Anticancer Research, 11/13/09
Relevance Score: 46%
Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
AIDS Research and Human Retroviruses, 10/23/09
Relevance Score: 46%
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Clinical Microbiology Reviews, 10/14/09
Relevance Score: 46%
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09
Relevance Score: 45%
Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus
Gerontology, 10/19/09
Relevance Score: 45%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09
The Basic Helix-loop-helix Proteins DEC1 and DEC2 Function as Corepressors of Retinoid X Receptors
Molecular Pharmacology, 11/25/09
Control of GluR2 translational initiation by its alternative 3'UTRs
Molecular Pharmacology, 11/25/09
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/25/09
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09
Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk Factors Associated with Methicillin Resistance among Staphylococcus aureus Infections in Veterans
Infection Control and Hospital Epidemiology, 11/25/09
Antiretroviral Drug-Resistant Mutations at Baseline and at Time of Failure of Antiretroviral Therapy in HIV Type 1-Coinfected TB Patients
AIDS Research and Human Retroviruses, 11/24/09
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


